Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors

Naunyn Schmiedebergs Arch Pharmacol. 2023 Apr;396(4):589-592. doi: 10.1007/s00210-023-02459-9.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents